Status:
COMPLETED
Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions
Lead Sponsor:
Perrigo Company
Conditions:
Bioequivalency
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Compare the rate and extent of absorption of two oral formulations of Ibuprofen 800 mg Tablets, administered as a single, one-tablet dose in fasted subjects.
Eligibility Criteria
Inclusion
- healthy men or women, 18 years of age or older
- body mass index between 19 and 30
- willing to participate and sign a copy of the informed consent form
Exclusion
- history of allergy or hypersensitivity to ibuprofen
- recent history of drug or alcohol addiction or abuse
- pregnant or lactating women
- use of tobacco products within 3 months prior to study dosing
- evidence of a clinically significant disorder or whose laboratory results were deemed to be clinically significant
- receipt of any drugs as part of a research study within 30 days prior to study dosing
Key Trial Info
Start Date :
January 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00804440
Start Date
January 1 2004
Last Update
March 16 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.